1. Home
  2. NVIV

NVIV

InVivo Therapeutics Holdings Corp

Logo InVivo Therapeutics Holdings Corp

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

0

InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury. The company's product pipeline consists of Neuro spinal scaffold and Bioengineered neural trails. The firm has a clinical development program for acute spinal cord injury and a preclinical development program for chronic spinal cord injury.

Founded: N/A Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: 995.9K IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 3.8M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -3.29 EPS Growth: N/A
52 Week Low/High: $0.22 - $2.40 Next Earning Date: 02-28-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: